Chad vs France: HIV/AIDS deaths averted by antiretroviral therapy
Chad
5,621 deaths
in 2024
France
5,635 deaths
in 2022
Chad rank
33rd
France rank
32nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Chad
- France
How they compare
France currently reports 5,635 deaths against 5,621 deaths in Chad, a difference of 14 deaths.
The two have swapped places 2 times across 33 shared years of data; in 1990 it was France ahead.
Chad ranks 33rd and France ranks 32nd of 157 countries.
France has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Chad | France | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 869.7 deaths | 869.7 deaths | France |
| 2000s | 925.64 deaths | 5,347 deaths | 4,421 deaths | France |
| 2010s | 3,844 deaths | 6,037 deaths | 2,193 deaths | France |
| 2020s | 4,740 deaths | 5,744 deaths | 1,004 deaths | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Chad or France?
- France, at 5,635 deaths against 5,621 deaths in Chad as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Chad and France?
- 14 deaths, with France ahead.
- How many years of comparable data are there for Chad and France?
- 33 years are reported by both, from 1990 to 2022.
- How do Chad and France rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Chad ranks 33rd and France ranks 32nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.